Ryan M. Confer

CIK: 0001735541

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (40.0%)

Compensation grants

Other (G, F, J, C, D, …)3 (60.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

GNPX

Genprex, Inc.

DirectorOfficer

Discretionary Trading P&L

Holdings

Transaction History (5 total)

GNPX
Genprex, Inc.
Feb 27, 2026
Tax Payment(F)
Direct
9.3K shares at avg. $2.00$19K
GNPX
Genprex, Inc.
Dec 22, 2025
Award(A)
Direct
45K shares-
GNPX
Genprex, Inc.
Jun 30, 2025
Tax Payment(F)
Direct
5.8K shares at avg. $0.23$1K
GNPX
Genprex, Inc.
Feb 18, 2025
Tax Payment(F)
Direct
395 shares at avg. $0.41$161.95
GNPX
Genprex, Inc.
Dec 5, 2024
Award(A)
Direct
29.4K shares-

		Type	Shares	Price		Ownership
Feb 27, 2026	GNPX Genprex, Inc.	Tax Payment(F)	9,330	$2.00	$18,660	Direct
Dec 22, 2025	GNPX Genprex, Inc.	Award(A)	45,000	-	-	Direct
Jun 30, 2025	GNPX Genprex, Inc.	Tax Payment(F)	5,775	$0.23	$1,316	Direct
Feb 18, 2025	GNPX Genprex, Inc.	Tax Payment(F)	395	$0.41	$162	Direct
Dec 5, 2024	GNPX Genprex, Inc.	Award(A)	29,375	-	$0	Direct

1-5 of 5 transactions

About Confer Ryan M.

Confer Ryan M. (SEC CIK 0001735541) files insider reports with the SEC as President, CEO and CFO of Genprex, Inc. (GNPX).

Signal8 holds 5 ownership filings by Confer Ryan M., all Form 4s, filed between Dec 6, 2024 and Feb 27, 2026. Those filings report 5 transactions, from Dec 5, 2024 to Feb 27, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Confer Ryan M.'s filings is in AUSTIN, TX.

Recent filings by Confer Ryan M.

Feb 27, 2026: Tax withholding of GNPX shares (Form 4, code F).
Dec 22, 2025: Grant or award of GNPX shares (Form 4, code A).
Jun 30, 2025: Tax withholding of GNPX shares (Form 4, code F).
Feb 18, 2025: Tax withholding of GNPX shares (Form 4, code F).
Dec 5, 2024: Grant or award of GNPX shares (Form 4, code A).

Other insiders filing for Genprex, Inc. (GNPX)

LONGNECKER BRENT M, Director
Berger Mark Stanley, Chief Medical Officer
Moreno Toscano Jose Antonio, Director
Wilson William R Jr., Director

How to read Form 4 transaction codes